BRCA1 Mutational Complementation Induces Synthetic Viability
- 4 June 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Cell
- Vol. 78 (5), 951-+
- https://doi.org/10.1016/j.molcel.2020.04.006
Abstract
No abstract availableFunding Information
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- U.S. Department of Defense
- Susan G. Komen for the Cure
This publication has 37 references indexed in Scilit:
- BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repairJournal of Cell Science, 2012
- Mouse models of Fanconi anemiaMutation research. Reviews in mutation research, 2009
- PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2Molecular Cancer Research, 2009
- PALB2 is an integral component of the BRCA complex required for homologous recombination repairProceedings of the National Academy of Sciences of the United States of America, 2009
- PALB2 Links BRCA1 and BRCA2 in the DNA-Damage ResponseCurrent Biology, 2009
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009
- Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexesGenes & Development, 2006
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Classification of BRCA1 missense variants of unknown clinical significanceJournal of Medical Genetics, 2005